Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis von Comenzo, R L, Reece, D, Palladini, G, Seldin, D, Sanchorawala, V, Landau, H, Falk, R, Wells, K, Solomon, A, Wechalekar, A, Zonder, J, Dispenzieri, A, Gertz, M, Streicher, H, Skinner, M, Kyle, R A, Merlini, G

Volltext

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma von Dimopoulos, M, Terpos, E, Comenzo, R L, Tosi, P, Beksac, M, Sezer, O, Siegel, D, Lokhorst, H, Kumar, S, Rajkumar, S V, Niesvizky, R, Moulopoulos, L A, Durie, B G M

Volltext

New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) von Ocio, E M, Richardson, P G, Rajkumar, S V, Palumbo, A, Mateos, M V, Orlowski, R, Kumar, S, Usmani, S, Roodman, D, Niesvizky, R, Einsele, H, Anderson, K C, Dimopoulos, M A, Avet-Loiseau, H, Mellqvist, U-H, Turesson, I, Merlini, G, Schots, R, McCarthy, P, Bergsagel, L, Chim, C S, Lahuerta, J J, Shah, J, Reiman, A, Mikhael, J, Zweegman, S, Lonial, S, Comenzo, R, Chng, W J, Moreau, P, Sonneveld, P, Ludwig, H, Durie, B G M, Miguel, J F S

Volltext

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders von Dispenzieri, A, Kyle, R, Merlini, G, Miguel, J S, Ludwig, H, Hajek, R, Palumbo, A, Jagannath, S, Blade, J, Lonial, S, Dimopoulos, M, Comenzo, R, Einsele, H, Barlogie, B, Anderson, K, Gertz, M, Harousseau, J L, Attal, M, Tosi, P, Sonneveld, P, Boccadoro, M, Morgan, G, Richardson, P, Sezer, O, Mateos, M V, Cavo, M, Joshua, D, Turesson, I, Chen, W, Shimizu, K, Powles, R, Rajkumar, S V, Durie, B G M

Volltext

Second primary malignancies in multiple myeloma: an overview and IMWG consensus von Musto, P., Anderson, K.C., Attal, M., Richardson, P.G., Badros, A., Hou, J., Comenzo, R., Du, J., Durie, B.G.M., San Miguel, J., Einsele, H., Chen, W.M., Garderet, L., Pietrantuono, G., Hillengass, J., Kyle, R.A., Moreau, P., Lahuerta, J.J., Landgren, O., Ludwig, H., Larocca, A., Mahindra, A., Cavo, M., Mazumder, A., McCarthy, P.L., Nouel, A., Rajkumar, S.V., Reiman, A., Riva, E., Sezer, O., Terpos, E., Turesson, I., Usmani, S., Weiss, B.M., Palumbo, A.

Volltext

Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group von Fernández de Larrea, C, Kyle, R A, Durie, B G M, Ludwig, H, Usmani, S, Vesole, D H, Hajek, R, San Miguel, J F, Sezer, O, Sonneveld, P, Kumar, S K, Mahindra, A, Comenzo, R, Palumbo, A, Mazumber, A, Anderson, K C, Richardson, P G, Badros, A Z, Caers, J, Cavo, M, LeLeu, X, Dimopoulos, M A, Chim, C S, Schots, R, Noeul, A, Fantl, D, Mellqvist, U-H, Landgren, O, Chanan-Khan, A, Moreau, P, Fonseca, R, Merlini, G, Lahuerta, J J, Bladé, J, Orlowski, R Z, Shah, J J

Volltext

Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis von Merlini, G, Lousada, I, Ando, Y, Dispenzieri, A, Gertz, M A, Grogan, M, Maurer, M S, Sanchorawala, V, Wechalekar, A, Palladini, G, Comenzo, R L

Volltext

Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis von Landau, H, Hassoun, H, Rosenzweig, M A, Maurer, M, Liu, J, Flombaum, C, Bello, C, Hoover, E, Riedel, E, Giralt, S, Comenzo, R L

Volltext

Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis von Landau, H, Smith, M, Landry, C, Chou, J F, Devlin, S M, Hassoun, H, Bello, C, Giralt, S, Comenzo, R L

Volltext

Management of treatment-emergent peripheral neuropathy in multiple myeloma von Richardson, P G, Delforge, M, Beksac, M, Wen, P, Jongen, J L, Sezer, O, Terpos, E, Munshi, N, Palumbo, A, Rajkumar, S V, Harousseau, J L, Moreau, P, Avet-Loiseau, H, Lee, J H, Cavo, M, Merlini, G, Voorhees, P, Chng, W J, Mazumder, A, Usmani, S, Einsele, H, Comenzo, R, Orlowski, R, Vesole, D, Lahuerta, J J, Niesvizky, R, Siegel, D, Mateos, M-V, Dimopoulos, M, Lonial, S, Jagannath, S, Bladé, J, Miguel, J San, Morgan, G, Anderson, K C, Durie, B G M, Sonneveld, P

Volltext

Predictors of survival in patients with systemic light‐chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan... von Lebovic, D., Hoffman, J., Levine, B. M., Hassoun, H., Landau, H., Goldsmith, Y., Maurer, M. S., Steingart, R. M., Cohen, A. D., Comenzo, R. L.

Volltext

Amyloid diseases of the heart: current and future therapies von DUBREY, S. W, COMENZO, R. L

Volltext

The Systemic Amyloidoses von Falk, Rodney H, Comenzo, Raymond L, Skinner, Martha

Volltext

Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis von Kaul, E, Shah, G, Chaulagain, C, Comenzo, R L

Volltext

Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects von Dubrey, S.W., Reece, D.E., Sanchorawala, V., Hegenbart, U., Merlini, G., Palladini, G., Fermand, J.-P., Vescio, R.A., Bladé, J., Heffner, L.T., Hassoun, H., Liu, X., Enny, C., Ramaswami, P., Elsayed, Y., Van De Velde, H., Mortimer, S., Cakana, A., Comenzo, R.L.

Volltext

International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantat... von Palumbo, A, Sezer, O, Kyle, R, Miguel, J S, Orlowski, R Z, Moreau, P, Niesvizky, R, Morgan, G, Comenzo, R, Sonneveld, P, Kumar, S, Hajek, R, Giralt, S, Bringhen, S, Anderson, K C, Richardson, P G, Cavo, M, Davies, F, Bladé, J, Einsele, H, Dimopoulos, M A, Spencer, A, Dispenzieri, A, Reiman, T, Shimizu, K, Lee, J H, Attal, M, Boccadoro, M, Mateos, M, Chen, W, Ludwig, H, Joshua, D, Chim, J, Hungria, V, Turesson, I, Durie, B G M, Lonial, S

Volltext

Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: experience at Memorial Sloan Kettering Cancer Center von Pozotrigo, M, Adel, N, Landau, H, Lesokhin, A, Lendvai, N, Chung, D J, Chimento, D, Riedel, E, Chen, X, Reich, L, Comenzo, R, Giralt, S, Hassoun, H

Volltext

High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: result... von SANCHORAWALA, V, WRIGHT, D. G, SKINNER, M, SELDIN, D. C, FALK, R. H, FINN, K. T, DEMBER, L. M, BERK, J. L, QUILLEN, K, ANDERSON, J. J, COMENZO, R. L

Volltext

Deep Venous Thrombosis and Thalidomide Therapy for Multiple Myeloma von Rajkumar, S. Vincent, Osman, Keren, Comenzo, Raymond

Volltext

Stem cell transplantation in patients with systemic AL amyloidosis referred for transplant after suboptimal responses to bortezomib-based initial therapy von Wong, S W, Larivee, D, Warner, M, Sprague, K A, Fogaren, T, Comenzo, R L

Volltext